Epilepsy News and Research

Latest Epilepsy News and Research

Eisai launches new class of epilepsy treatment Fycompa in France

Fycompa (perampanel), the first in an entirely new class of treatment for partial onset seizures (the most common form of epilepsy), has today received reimbursement approval from the Comité Economique des Produits de Santé.

22 May 2014

Researchers develop potential route to new therapies for treatment of Parkinson's disease

A biologist and a psychologist at the University of York have joined forces with a drug discovery group at Lundbeck in Denmark to develop a potential route to new therapies for the treatment of Parkinson's Disease (PD).

16 May 2014

Depression is the leading cause of illness in adolescents, shows WHO's report

WHO's "Health for the world's adolescents" report reveals that depression is the predominant cause of illness and disability for both boys and girls aged 10 to 19 years.

15 May 2014

Global scientists to discuss latest findings on diagnosis, causes and treatments of ASD

The International Society for Autism Research (INSAR), a scientific and professional organization devoted to advancing knowledge about autism spectrum disorders, convened more than 1700 researchers, delegates, autism specialists and students from 40 countries for the 13th Annual International Meeting for Autism Research (IMFAR), the world's largest scientific gathering on autism research, from May 15 through May 17 at the Atlanta Marriott Marquis in Atlanta, GA.

15 May 2014

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

Epilepsy is a group of neurological disorders often characterized by seizures and cognitive impairment due to electrical disturbances in the brain.

From Quest Diagnostics 14 May 2014

Prolong exposure to paint, glue is detrimental for brain

People who are exposed to paint, glue or degreaser fumes at work may experience memory and thinking problems in retirement, decades after their exposure, according to a study published in the May 13, 2014, print issue of Neurology®, the medical journal of the American Academy of Neurology.

13 May 2014

GE Healthcare, Tesla Engineering announce collaboration to develop ultra high-field MRI systems

Today at the joint meeting of the International Society for Magnetic Resonance in Medicine and the European Society for Magnetic Resonance in Medicine and Biology, GE Healthcare and Tesla Engineering Ltd. announced that they will collaborate together to produce 7.0 tesla (7.0T) human whole-body magnetic resonance imaging (MRI) scanners, and build upon the ten year history of GE innovations in this advanced, technical field.

12 May 2014

First Edition: May 9, 2014

Today's headlines include highlights from the first Senate confirmation hearing for Sylvia Mathews Burwell, President Barack Obama's pick for Health and Human Services Secretary.

9 May 2014

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

A drug typically prescribed for erectile dysfunction or increased pressure in the arteries may help improve blood flow in the muscles of boys with Duchenne muscular dystrophy, according to a study published in the May 7, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.

8 May 2014

People who have uncontrolled seizures are at heightened risk for SUDEP

One in 26 Americans will develop epilepsy over the course of a lifetime leading to nearly three million Americans now living with epilepsy. For nearly one-third of them, their seizures are uncontrolled by medicine and other common forms of treatment.

6 May 2014

Calgary researcher receives $130,000 grant to develop clinical decision tools to aid epilepsy research

A researcher from the University of Calgary is receiving $130,000 to develop clinical decision tools to aid a physician's understanding of how a patient will respond to different treatments.

6 May 2014

Acorda gets FDA Complete Response Letter for PLUMIAZ Nasal Spray NDA

Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for PLUMIAZ (diazepam) Nasal Spray for the treatment of people with epilepsy who experience cluster seizures.

2 May 2014

Scientists find key information that may lead to new therapeutic approaches to epilepsy

A team of researchers from Sanford-Burnham Medical Research Institute (Sanford-Burnham) and SUNY Downstate Medical Center (SUNY Downstate) has found that deficiencies in hyaluronan, also known as hyaluronic acid or HA, can lead to spontaneous epileptic seizures.

2 May 2014

Astrocytes malfunction may contribute to neurodegenerative disorders

Scientists studying brain diseases may need to look beyond nerve cells and start paying attention to the star-shaped cells known as "astrocytes," because they play specialized roles in the development and maintenance of nerve circuits and may contribute to a wide range of disorders, according to a new study by UC San Francisco researchers.

29 Apr 2014

AAN review finds certain forms of medical marijuana can help treat some symptoms of MS

A review by the American Academy of Neurology of available scientific research on the use of medical marijuana in brain diseases finds certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but do not appear to be helpful in treating drug-induced (levodopa) movements in Parkinson's disease.

29 Apr 2014

Life stressors may activate neurological disorders

When mothers are exposed to trauma, illness, alcohol or other drug abuse, these stressors may activate a single molecular trigger in brain cells that can go awry and activate conditions such as schizophrenia, post-traumatic stress disorder and some forms of autism.

26 Apr 2014

State highlights: Home care workers' pay and Medicaid budgets; Calif. mental health grants; NYU ER reopens

A new rule from the Obama administration designed to provide better pay and working conditions to 2 million home care workers is forcing many states to rethink how they look at Medicaid payments and may result in higher Medicaid costs. Starting Jan. 1, home care workers in 29 states will, for the first time, be eligible for the federal minimum wage of $7.25 an hour and overtime pay, under a new regulation from the U.S. Department of Labor. These workers go to homes of the elderly and the disabled to help with cooking, bathing and other daily tasks, and are paid by the clients or through Medicaid (Prah, 4/25).

26 Apr 2014

New data from EMD Serono's multiple sclerosis portfolio to be presented at the 66th AAN Annual Meeting

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66th Annual Meeting, taking place from April 26 – May 3, in Philadelphia, PA.

26 Apr 2014

Biologists identify how T-type channels change electrochemical signaling of heart and brain cells

Biologists have discovered how an outer shield over T-type channels change the electrochemical signaling of heart and brain cells. Understanding how these shields work will help researchers eventually develop a new class of drugs for treating epilepsy, cardiovascular disease and cancer.

26 Apr 2014

Graphene may lead to new applications in the diagnosis and treatment of neurological diseases

The development of graphene-a highly advanced metamaterial with many unique and varied properties-may lead to exciting new applications in the diagnosis and treatment of neurological diseases, according to a report in the May issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

26 Apr 2014

Epilepsy News and Research

Latest Epilepsy News and Research

Eisai launches new class of epilepsy treatment Fycompa in France

Researchers develop potential route to new therapies for treatment of Parkinson's disease

Depression is the leading cause of illness in adolescents, shows WHO's report

Global scientists to discuss latest findings on diagnosis, causes and treatments of ASD

Autoimmune epilepsy diagnostics: an interview with Dr. Joseph J. Higgins, Medical Director, Neurology, Athena Diagnostics, a business of Quest Diagnostics

Prolong exposure to paint, glue is detrimental for brain

GE Healthcare, Tesla Engineering announce collaboration to develop ultra high-field MRI systems

First Edition: May 9, 2014

Common drug may improve blood flow in muscles of boys with Duchenne muscular dystrophy

People who have uncontrolled seizures are at heightened risk for SUDEP

Calgary researcher receives $130,000 grant to develop clinical decision tools to aid epilepsy research

Acorda gets FDA Complete Response Letter for PLUMIAZ Nasal Spray NDA

Scientists find key information that may lead to new therapeutic approaches to epilepsy

Astrocytes malfunction may contribute to neurodegenerative disorders

AAN review finds certain forms of medical marijuana can help treat some symptoms of MS

Life stressors may activate neurological disorders

State highlights: Home care workers' pay and Medicaid budgets; Calif. mental health grants; NYU ER reopens

New data from EMD Serono's multiple sclerosis portfolio to be presented at the 66th AAN Annual Meeting

Biologists identify how T-type channels change electrochemical signaling of heart and brain cells

Graphene may lead to new applications in the diagnosis and treatment of neurological diseases

Everything you need to know about epilepsy eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Epilepsy News and Research

Latest Epilepsy News and Research

Everything you need to know about epilepsy eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in